Energy-based technologies and treatments exist for virtually all clinical specialties. Given the ability of these technologies, particularly ablation technologies, to very precisely destroy tissue, they have been strongly developed for cancer applications and much success has already been achieved in producing treatments that have low risk, short recovery times and good long term outcomes. Cost is non insignificant for these technologies, but thus far their clinical benefits have generally supported strong reimbursement.
Energy-based cancer treatment regimens consist of external beam radiation therapy, brachytherapy and a number of newer applications of energy therapies that ablate cancerous tissue. Prostate cancer for example, the most prevalent cancer among U.S. men, can now be treated with a range of energy based therapies that effectively supplement chemotherapy and other targeted therapeutics.
Souce: MedMarket Diligence, LLC, Report #A125: "Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities." See link for report description, detailed table of contents and list of exhibits.
The range of energy modalities used for ablation in cancer include the following:
- microwave ablation
- radiation therapy
- radiofrequency (RF) ablation
- stereotactic surgery
- laser ablation
- photodynamic therapy
- ultrasonic ablation
As well, there are combinations of the above, and several of these (e.g., radiation therapy) have many variations in the way they can be delivered (note, for example, the overlap between brachytherapy, radiation therapy and stereotactic surgery).